Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy.

Biomed Res Int · 2023 · PMC10697779 · PMID 38058393

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Consistent with the previous reports [ 18 , 19 , 21 ], treatment with ASP7657 significantly increased the population of CD8 + T cells and showed a trend towards increasing CD4 + and total T cells in tumors.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.